Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Mylan
3088
Mylan
Official page for Mylan, where we work around the clock and around the globe to help provide 7 billion people access to high quality medicine
Suggest edits
Follow us
Alexa global traffic share
Twitter followers
Overview
Apps
7
Add info
Team Size
10000+
Employees
I work here
Location
United States
Headquarters
Explore United States
MedCity News
Biogen fends off Mylan’s challenge to patent on top-selling multiple sclerosis drug
Reuters Top News
Mylan to pay $30 million U.S. SEC fine related to EpiPen overcharge probe
Reuters Top News
Denmark's Novo Nordisk files lawsuit against Mylan over patent
Reuters Top News
,
Xconomy
Pfizer to merge generics unit with Mylan; seeks to sharpen cancer...
PE HUB
Mylan to merge with Upjohn
Reuters Top News
Pfizer in talks to merge off-patent drugs business with Mylan: source
Bloomberg
Mylan Critic Blumenthal Asks FDA to Help End EpiPen Shortage
Health
Manufacturing
Ars Technica
72% of Mylan shareholders think Heather Bresch is doing great—just overpaid
Strategy
Ars Technica
Mylan board survives shareholder vote, but gets pushback on its compensation
Strategy
Ars Technica
With help of coal tax credits, Mylan had a negative 294-percent tax rate in 2016
Stock markets
Strategy
Ars Technica
Mylan chairman: Drug pricing critics ought to go copulate with themselves
Costs
Communities
Health
Quartz
How Mylan got away with overcharging Medicaid $1.3 billion for EpiPen
Health
Privacy
Ars Technica
Mylan shareholders revolt, say directors’ greed has gone too far
Stock markets
Ars Technica
Mylan bullied, sued states to get them to use EpiPens, court documents show
Legal
Health
Ars Technica
FDA lashes out at Mylan for dismal quality control at HIV drug facility
Health
Ars Technica
Despite what Mylan said, its price hikes hit patients’ wallets hard
Health
Costs
Earnings
The Verge
EpiPen maker Mylan is under investigation by the Federal Trade Commission
US elections
Ars Technica
For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million
Health
Costs
Privacy
Slashdot
Feds Go After Mylan For Scamming Medicaid Out of Millions On EpiPen Pricing
Ars Technica
Mylan CEO misled lawmakers about EpiPen profits—they’re 66% higher
Earnings